Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans
about
The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promiseMitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathyRole of estrogen in diastolic dysfunctionSex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusObesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female miceEffects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjectsType 2 diabetes, obesity, and sex difference affect the fate of glucose in the human heartMineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected AdultsEndothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer.Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.A Diet Rich in Medium-Chain Fatty Acids Improves Systolic Function and Alters the Lipidomic Profile in Patients With Type 2 Diabetes: A Pilot Study.Relationships among HIV infection, metabolic risk factors, and left ventricular structure and functionA "PET" area of interest: myocardial metabolism in human systolic heart failure.Sex-specific predictors of left ventricular diastolic dysfunction in untreated hypertension.Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetesRecent advances in metabolic imaging.Vascular imaging in diabetes.Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.Imaging of myocardial fatty acid oxidation.Cardiovascular consequences of metabolic syndrome.Cardiac nuclear receptors: architects of mitochondrial structure and function.Left ventricular metabolism, function, and sympathetic innervation in men and women with type 1 diabetes.Sex affects myocardial blood flow and fatty acid substrate metabolism in humans with nonischemic heart failure.Manifestations and mechanisms of myocardial lipotoxicity in obesity.Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span.The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin.Diabetic Cardiomyopathy: Distinct and Preventable Entity or Inevitable Consequence?
P2860
Q26829731-5E54D28D-94D7-40DC-9FF7-E7CB714E9F47Q26859582-635BB7C1-DA0E-43CC-A356-1096359D0B52Q27026798-8ED6D88B-0F53-424A-818C-A47E6F5D274EQ28395801-D1C7CE1F-36C8-48FC-984D-CEE6E38FF539Q33584753-C5C37FE1-4F8A-4F1D-A5CD-5D91CBD7F80DQ33644666-2DA51337-0DF3-429C-B93D-C941AEE64CDCQ33708984-976240A7-AB8E-4A06-837C-0B6ED320EF26Q34186806-6A1370C3-513F-4C05-9E4C-55F6B942B77BQ35749621-9F4478E7-B1CE-458E-927B-C9183AA765FDQ36000073-7E869806-6A91-45DC-8D19-A34E08CC069CQ36208623-DA744E89-97C9-4FD3-A489-D34A34CFA5CAQ36277736-11E243FD-A5D0-474B-8C40-E41FF37CC95AQ36698721-CEBEF21A-8677-4FB4-8D62-450F3EAFBE9CQ36885497-F1803603-BED6-4175-9018-E7CDDB30FC76Q36935401-AFC76B07-E72C-41F2-AA60-D5513E3534AEQ37025613-B40301F1-2265-4315-99AB-02F3FFDDC1AEQ37086847-0D22DED8-F90E-43C2-A6BA-39F38DC65231Q37385208-DDCF1611-DD81-4F71-97C8-CCFDFAEACA2AQ37458369-F0E9E98D-2590-4B75-880A-802C0C5A6319Q37586729-61CB457D-1347-4330-857A-D5ACE644129DQ38156683-D6CB3446-F41F-4775-B68D-47C91EA1E494Q38184961-F52BF520-8E61-4E3B-B0A1-FE45816AEE17Q38427211-110270F2-F575-49FD-95C3-5ECA6CF345BCQ38753602-64A91ABA-D81E-4600-86CF-1070D7F87018Q39106973-66C0821E-9093-41F3-AB2E-DBF355BF9C92Q39133516-CC3E5D2A-768A-41F7-917E-75AF2B4CE458Q41650323-576E437A-B806-49FE-B2F4-6217CB0B3C38Q41771740-85649066-453E-4904-B8D1-67B9AEAAD17EQ48249334-4A02E41E-353F-4BDB-86C5-E13666005244Q50193085-AAAFD0A7-07B8-4242-B937-AC4BCD0F64A7Q52718518-18B6C54A-4B3D-4D7F-A4BA-E8645933F04CQ59192076-FB36062D-AD49-48F6-B4A3-F04DF9182121
P2860
Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@ast
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@en
type
label
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@ast
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@en
prefLabel
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@ast
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@en
P2093
P2860
P356
P1433
P1476
Sex and type 2 diabetes: obesi ...... olism and relaxation in humans
@en
P2093
Amanda J DeMoss
Andrew R Coggan
Carmen S Dence
Carol L Recklein
Ibrahim M Saeed
Janet B McGill
Kenneth B Schechtman
Linda R Peterson
Pilar Herrero
Ratnasiri Gunawardena
P2860
P304
P356
10.1038/OBY.2011.208
P577
2011-08-04T00:00:00Z